Abstract
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms and the selective loss of dopaminergic neurons. The etiology of idiopathic PD is likely a combination of genetic and environmental factors. Despite findings from mammalian studies that have provided significant insight into the disorder, the molecular mechanisms underlying its pathophysiology are still poorly understood. The nematode Caenorhabditis elegans (C. elegans) is a powerful system for genetic analysis. Considering C. elegans short lifespan, fully sequenced genome, high genetic and neurobiochemical conservation with humans, as well as the availability of facile genetic tools, the nematode represents a highly efficient and effective model system to explore the molecular basis of PD. In this review we describe the utility of C. elegans for PD research, and the opportunity the model system presents to identify therapeutic targets.
Keywords: Nematode, dopamine, Parkinson’s disease, neurodegeneration, neuroprotection, dopaminergic neurons, mammalian studies, pathophysiology, Caenorhabditis, therapeutic targets.
CNS & Neurological Disorders - Drug Targets
Title:C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets
Volume: 11 Issue: 8
Author(s): Julia Vistbakka, Natalia VanDuyn, Garry Wong and Richard Nass
Affiliation:
Keywords: Nematode, dopamine, Parkinson’s disease, neurodegeneration, neuroprotection, dopaminergic neurons, mammalian studies, pathophysiology, Caenorhabditis, therapeutic targets.
Abstract: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms and the selective loss of dopaminergic neurons. The etiology of idiopathic PD is likely a combination of genetic and environmental factors. Despite findings from mammalian studies that have provided significant insight into the disorder, the molecular mechanisms underlying its pathophysiology are still poorly understood. The nematode Caenorhabditis elegans (C. elegans) is a powerful system for genetic analysis. Considering C. elegans short lifespan, fully sequenced genome, high genetic and neurobiochemical conservation with humans, as well as the availability of facile genetic tools, the nematode represents a highly efficient and effective model system to explore the molecular basis of PD. In this review we describe the utility of C. elegans for PD research, and the opportunity the model system presents to identify therapeutic targets.
Export Options
About this article
Cite this article as:
Vistbakka Julia, VanDuyn Natalia, Wong Garry and Nass Richard, C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets, CNS & Neurological Disorders - Drug Targets 2012; 11 (8) . https://dx.doi.org/10.2174/1871527311211080004
DOI https://dx.doi.org/10.2174/1871527311211080004 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Histamine as a Potential Adjuvant to Immuno and Radiotherapy for Cancer Treatment: Discovering New Functions for the Oldest Biogenic Amine
Current Immunology Reviews (Discontinued) L-Arginine Transport in Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Microcirculation in Sepsis: New Perspectives
Current Vascular Pharmacology Ethnicity and Drug Therapy for Hypertension
Current Pharmaceutical Design Isolated Perioperative Hypertension: Clinical Implications & Contemporary Treatment Strategies
Current Hypertension Reviews Safe and Effective Delivery of Amphotericin B: A Survey of Patents
Recent Patents on Nanotechnology Vasorelaxation Caused by Cannabinoids: Mechanisms in Different Vascular Beds
Current Vascular Pharmacology Syncope: Review of Monitoring Modalities
Current Cardiology Reviews Heart Failure Pharmacotherapy: Differences Between Adult and Paediatric Patients
Current Medicinal Chemistry Off-Label Trazodone Prescription: Evidence, Benefits and Risks
Current Pharmaceutical Design A Review of the Chemical and Pharmacological Aspects of the Genus Marrubium
Current Pharmaceutical Design Hyperglycemia and Perioperative Glucose Management
Current Pharmaceutical Design New Targets of Therapy in T-Cell Lymphomas
Current Drug Targets B-Type Natriuretic Peptide: Endogenous Regulator of Myocardial Structure, Biomarker and Therapeutic Target
Current Molecular Medicine microRNAs: Innovative Targets for Cerebral Ischemia and Stroke
Current Drug Targets Beta-Blocker Therapy for Septic Cardiac Shock: Fiction Or Realism?
Current Drug Therapy Myogenic Properties of Brain and Cardiac Vessels and their Relation to Disease
Current Vascular Pharmacology Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Current Cancer Drug Targets Empowering Translational Research in Fetal Growth Restriction: Sheep and Swine Animal Models
Current Pharmaceutical Biotechnology Bombacaceae Between the Ethnomedical Uses and Pharmacological Evidences: A Review
The Natural Products Journal